-
J KOREAN PHYS SOC 2024 10.1007/s40042-024-01166-9
Utility of a patient-specific aperture collimator and multi-leaf collimator in line scanning proton therapy
Ko, M; Jeon, C; Ahn, SH; Han, Y; Chung, K; Cho, S; Jo, K; Shin, EH; Lee, S; Lee, W; Oh, Y; Kim, J; Kang, S; Park, HC; Lee, K
View PubMed
-
ANTICANCER RES 2024 10.21873/anticanres.17029
Proton Beam Radiotherapy as a Curative Alternative to Radiofrequency Ablation for Newly Diagnosed Hepatocellular Carcinoma
Seo, SH; Yu, JI; Park, HC; Yoo, GS; Choi, MS; Rhim, H; Lee, MW; Han, S; Park, B; Shim, JS
View PubMed
-
CLIN TRANSL RAD ONCO 2024 10.1016/j.ctro.2024.100732
Impact and optimal timing of local therapy addition in borderline resectable or locally advanced pancreatic cancer after FOLFIRINOX chemotherapy
Kim, K; Park, HC; Yu, JI; Park, JO; Hong, JY; Lee, KT; Lee, KH; Lee, JK; Park, JK; Heo, JS; Shin, SH; Min, JH; Kim, K; Han, IW
View PubMed
-
JHEP REP 2024 10.1016/j.jhepr.2023.100991
Concurrent nivolumab and external beam radiation therapy for hepatocellular carcinoma with macrovascular invasion: A phase II study
Kim, BH; Park, HC; Kim, TH; Koh, YH; Hong, JY; Cho, Y; Sinn, DH; Park, B; Park, JW
View PubMed
-
CANCER MED-US 2024 10.1002/cam4.7023
A meta-analysis comparing efficacy and safety between proton beam therapy versus carbon ion radiotherapy
Jang, JY; Kim, K; Chen, MF; Akimoto, T; Wang, MLC; Kim, MJ; Kim, K; Lee, TH; Yoo, GS; Park, HC
View PubMed
-
PRACT RADIAT ONCOL 2024 10.1016/j.prro.2023.08.016
Defining Minimum Treatment Parameters of Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma: An Expert Consensus
Yanagihara, TK; Tepper, JE; Moon, AM; Barry, A; Molla, M; Seong, J; Torres, F; Apisarnthanarax, S; Buckstein, M; Cardenes, H; Chang, DT; Feng, MRY; Guha, C; Hallemeier, CL; Hawkins, MA; Hoyer, M; Iwata, H; Jabbour, SK; Kachnic, L; Kharofa, J; Kim, TH; Kirichenko, A; Koay, EJ; Makishima, H; Mases, J; Meyer, JJ; Munoz-Schuffenegger, P; Owen, D; Park, HC; Saez, J; Sanford, NN; Scorsetti, M; Smith, GL; Wo, JY; Yoon, SM; Lawrence, TS; Reig, M; Dawson, LA
View PubMed
-
J KOREAN PHYS SOC 2024 10.1007/s40042-023-00998-1
Search for practical scaling factors of Bragg peak arrangement for line-scanning proton beam therapy in RayStation
Chung, K; Kim, N; Cho, WK; Kim, H; Oh, D; Park, W; Park, HC; Lim, D
View PubMed
-
CANCERS 2023 10.3390/cancers15204914
The Current Evidence of Intensity-Modulated Radiotherapy for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
Jang, WI; Jo, S; Moon, JE; Bae, SH; Park, HC
View PubMed
-
RADIOTHER ONCOL 2023 10.1016/j.radonc.2023.109841
External validation of subclassification system and progression pattern analysis in hepatocelluar carcinoma with macroscopic vascular invasion
Yu, JI; Park, HC; Shin, H; Park, H; Shin, SW; Cho, SK; Hyun, D; Shin, J; Goh, MJ; Choi, MS; Park, B; Yoon, SM; Jung, JH
View PubMed
-
J KOREAN PHYS SOC 2023 10.1007/s40042-023-00897-5
Searching for optimized selection of Monte Carlo dose calculation parameters for scanned beam proton therapy in RayStation
Kim, H; Chung, KZ; Han, YY; Park, W; Park, HC; Lim, D; Choi, DH
View PubMed
-
MED PHYS 2023 10.1002/mp.16575
FLASH dose rate calculation based on log files in proton pencil beam scanning therapy
Jeon, C; Ahn, S; Amano, D; Kamiguchi, N; Cho, S; Sheen, H; Park, HC; Han, Y
View PubMed
-
CANCER RES TREAT 2023 10.4143/crt.2022.1646
One-Week versus Two-Week Chemoradiotherapy Followed by Curative Surgery in Rectal Cancer: Long-Term Comparative Pooled Analysis of Two Prospective Multicenter Phase II Trials
Sung, SY; Kim, DY; Jang, HS; Kim, TH; Park, HC; Chie, EK; Nam, TK; Kim, SH; Lee, JH
View PubMed
-
LIVER CANCER 2023 10.1159/000529635
Impact of Intrahepatic External Beam Radiotherapy in Advanced Hepatocellular Carcinoma Patients Treated with Tyrosine Kinase Inhibitors
Goh, MJ; Park, HC; Yu, JI; Kang, WS; Gwak, GY; Paik, YH; Lee, JH; Koh, KC; Paik, SW; Sinn, DH; Choi, MS
View PubMed
-
CANCER MED-US 2023 10.1002/cam4.5530
Comprehensive immunoprofile analysis of prognostic markers in pancreaticobiliary tract cancers
Kim, JE; Kim, H; Kim, B; Chung, HG; Chung, HH; Kim, KM; Kim, SH; Jeong, WK; Kim, YK; Min, JH; Heo, JS; Han, IW; Shin, SH; Park, HC; Yu, JI; Park, JO; Kim, ST; Hong, JY; Lee, SH; Lee, KH; Lee, JK; Lee, KT; Jang, KT; Park, JK
View PubMed
-
CANCER RES TREAT 2023 10.4143/crt.2021.1527
A Phase II Study of Preoperative Chemoradiotherapy with Capecitabine Plus Simvastatin in Patients with Locally Advanced Rectal Cancer
Jo, H; Kim, ST; Lee, JY; Park, SH; Park, JO; Park, YS; Lim, HY; Il Yu, J; Park, HC; Choi, DH; Park, Y; Cho, YB; Huh, JW; Yun, SH; Kim, HC; Lee, WY; Kang, WK
View PubMed
-
FRONT ONCOL 2022 10.3389/fonc.2022.960527
Clinical implication and management of rectal cancer with clinically suspicious lateral pelvic lymph node metastasis: A radiation oncologist's perspective
Yoo, GS; Park, HC; Yu, JI
View PubMed
-
RADIOTHER ONCOL 2022 10.1016/j.radonc.2022.09.003
A phase II trial of hypofractionated high-dose proton beam therapy for unresectable liver metastases
Kim, K; Il Yu, J; Park, HC; Yoo, GS; Lim, D; Noh, JM; Jeong, WK
View PubMed
-
INT J MOL SCI 2022 10.3390/ijms232112923
Dual Oxidase 2 (DUOX2) as a Proteomic Biomarker for Predicting Treatment Response to Chemoradiation Therapy for Locally Advanced Rectal Cancer: Using High-Throughput Proteomic Analysis and Machine Learning Algorithm
Lee, H; Ryu, HS; Park, HC; Yu, JI; Yoo, GS; Choi, C; Nam, H; Lee, JJB; Do, IG; Han, D; Ha, SY
View PubMed
-
CANCERS 2022 10.3390/cancers14194556
The Feasibility of Stereotactic Body Proton Beam Therapy for Pancreatic Cancer
Shin, H; Yu, JI; Park, HC; Yoo, GS; Cho, S; Park, JO; Lee, KT; Lee, KH; Lee, JK; Park, JK; Heo, JS; Han, IW; Shin, SH
View PubMed
-
INT J RADIAT BIOL 2022 10.1080/09553002.2022.2094020
Radiotherapy for bone metastases of hepatocellular carcinoma: a hybrid systematic review with meta-analyses
Rim, CH; Park, S; Yoon, WS; Shin, IS; Park, HC
View PubMed
-
FRONT ONCOL 2022 10.3389/fonc.2022.928119
Trends in radiotherapy administration in the management of hepatocellular carcinoma: Analysis of a Korean tertiary hospital registry of hepatocellular carcinoma patients diagnosed between 2005 and 2017
Bae, BK; Park, HC; Yu, JI; Yoo, GS; Sinn, DH; Choi, MS; Oh, JH
View PubMed
-
RADIAT ONCOL 2022 10.1186/s13014-022-02100-8
Assessment of dose perturbations for metal stent in photon and proton radiotherapy plans for hepatocellular carcinoma
Lee, B; Cho, S; Park, HC; Kang, SW; Kim, JS; Chung, JB
View PubMed
-
CANCERS 2022 10.3390/cancers14092081
The Significance of Systemic Inflammation Markers in Intrahepatic Recurrence of Early-Stage Hepatocellular Carcinoma after Curative Treatment
Bae, BK; Park, HC; Yoo, GS; Choi, MS; Oh, JH; Yu, JI
View PubMed
-
FRONT ONCOL 2022 10.3389/fonc.2022.888755
Safety and Efficacy of Liver-Directed Radiotherapy in Combination With Lenvatinib for Hepatocelluar Carcinoma With Macroscopic Tumor Thrombosis
Yu, JI; Kang, W; Yoo, GS; Goh, MJ; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Hong, JY; Lim, HY; Park, B; Park, HC
View PubMed
-
ANN SURG ONCOL 2022 10.1245/s10434-022-11688-w
ASO Visual Abstract: Determining Which Patients Require Preoperative Pelvic Radiotherapy Before Curative Intent Surgery and/or Ablation for Metastatic Rectal Cancer
Yu, JI; Yoo, GS; Park, HC; Choi, DH; Lee, WY; Yun, SH; Kim, HC; Cho, YB; Huh, JW; Park, YA; Shin, JK; Park, JO; Kim, ST; Park, YS; Lee, J; Kang, WK; Lim, HY; Hong, JY
View PubMed
-
ANN SURG ONCOL 2022 10.1245/s10434-022-11592-3
Determining Which Patients Require Preoperative Pelvic Radiotherapy Before Curative-Intent Surgery and/or Ablation for Metastatic Rectal Cancer
Yu, JI; Yoo, GS; Park, HC; Choi, DH; Lee, WY; Yun, SH; Kim, HC; Cho, YB; Huh, JW; Park, YA; Shin, JK; Park, JO; Kim, ST; Park, YS; Lee, J; Kang, WK; Lim, HY; Hong, JY
View PubMed
-
JPN J CLIN ONCOL 2022 10.1093/jjco/hyac028
Stereotactic ablative radiotherapy for pulmonary oligometastases from primary hepatocellular carcinoma: a multicenter and retrospective analysis (KROG 17-08)
Jo, IY; Park, HC; Kim, ES; Yeo, SG; Kim, M; Seong, J; Kim, JW; Kim, TH; Yoon, WS; Jeong, BK; Kim, SH; Lee, JH
View PubMed
-
GENOME MED 2022 10.1186/s13073-021-00995-8
Hepatocellular carcinoma patients with high circulating cytotoxic T cells and intra-tumoral immune signature benefit from pembrolizumab: results from a single-arm phase 2 trial
Hong, JY; Cho, HJ; Sa, JK; Liu, XQ; Ha, SY; Lee, T; Kim, H; Kang, W; Sinn, DH; Gwak, GY; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Park, HC; Kang, TW; Rhim, H; Lee, SJ; Cristescu, R; Lee, J; Paik, YH; Lim, HY
View PubMed
-
INT J MOL SCI 2022 10.3390/ijms23020587
High-Throughput 3D Tumor Spheroid Array Platform for Evaluating Sensitivity of Proton-Drug Combinations
Lee, DW; Kim, JE; Lee, GH; Son, A; Park, HC; Oh, D; Jo, K; Choi, C
View PubMed
-
PHARMACEUTICS 2021 10.3390/pharmaceutics13111811
Antigen-Capturing Mesoporous Silica Nanoparticles Enhance the Radiation-Induced Abscopal Effect in Murine Hepatocellular Carcinoma Hepa1-6 Models
Yang, K; Choi, C; Cho, H; Ahn, WG; Kim, SY; Shin, SW; Kim, Y; Jang, T; Lee, N; Park, HC
View PubMed
-
J BONE ONCOL 2021 10.1016/j.jbo.2021.100368
Clinical and dosimetric risk factors for vertebral compression fracture after single-fraction stereotactic body radiation therapy for spine metastases
Kim1, H; Pyo, H; Park, HC; Lim, DH; Yu, JI; Park, W; Ahn, YC; Choi, DH; Oh, D; Noh, JM; Cho, WK; Yoo, GS; Jung, SH; Kim, ES; Lee, SH; Park, SJ; Lee, CS
View PubMed
-
SCI REP-UK 2021 10.1038/s41598-021-90065-1
Diffusion-weighted and dynamic contrast-enhanced magnetic resonance imaging after radiation therapy for bone metastases in patients with hepatocellular carcinoma
Lee1, JH; Yoo, GS; Yoon, YC; Park, HC; Kim, HS
View PubMed
-
INT J MOL SCI 2021 10.3390/ijms22052637
Manganese Ferrite Nanoparticles Enhance the Sensitivity of Hepa1-6 Hepatocellular Carcinoma to Radiation by Remodeling Tumor Microenvironments
Shin1, SW; Yang, K; Lee, M; Moon, J; Son, A; Kim, Y; Choi, S; Kim, D; Choi, C; Lee, N; Park, HC
View PubMed
-
CELLS 2021 10.3390/cells10030554
Downregulation of Mcl-1 by Panobinostat Potentiates Proton Beam Therapy in Hepatocellular Carcinoma Cells
Choi1, C; Lee, GH; Son, A; Yoo, GS; Yu, JI; Park, HC
View PubMed
-
SCI REP-UK 2021 10.1038/s41598-021-82177-5
Clinical importance of the absolute count of neutrophils, lymphocytes, monocytes, and platelets in newly diagnosed hepatocellular carcinoma
Yu1, JI; Park, HC; Yoo, GS; Choi, C; Choi, MS; Nam, H; Baek, SY; Park, M
View PubMed
-
CLIN MOL HEPATOL 2021 10.3350/cmh.2020.0095
Radiation-induced abscopal effect and its enhancement by programmed cell death 1 blockade in the hepatocellular carcinoma: A murine model study
Yoo1, GS; Ahn, WG; Kim, SY; Kang, W; Choi, C; Park, HC
View PubMed
-
CANCER IMMUNOL IMMUN 2020 10.1007/s00262-020-02794-3
Incorporating sarcopenia and inflammation with radiation therapy in patients with hepatocellular carcinoma treated with nivolumab
Kim1, N; Yu, JI; Park, HC; Yoo, GS; Choi, C; Hong, JY; Lim, HY; Lee, J; Choi, MS; Lee, JE; Kim, K
View PubMed
-
MAR DRUGS 2020 10.3390/md18100500
Therapeutic Potential of (-)-Agelamide D, a Diterpene Alkaloid from the Marine Sponge Agelas sp., as a Natural Radiosensitizer in Hepatocellular Carcinoma Models
Choi1, C; Cho, Y; Son, A; Shin, SW; Lee, YJ; Park, HC
View PubMed
-
CANCERS 2020 10.3390/cancers12092395
Do Biliary Complications after Proton Beam Therapy for Perihilar Hepatocellular Carcinoma Matter?
Yoo1, GS; Il Yu, J; Park, HC; Hyun, D; Jeong, WK; Lim, HY; Choi, MS; Ha, SY
View PubMed
-
MAR DRUGS 2020 10.3390/md18080377
Topical Application of Phlorotannins from Brown Seaweed Mitigates Radiation Dermatitis in a Mouse Model
Yang1, K; Kim, SY; Park, JH; Ahn, WG; Jung, SH; Oh, D; Park, HC; Choi, C
View PubMed
-
INT J COLORECTAL DIS 2020 10.1007/s00384-020-03701-z
Determining whether postoperative chemoradiotherapy is required in patients with pathologic T3N0 rectal cancer with negative resection margin
Baek1, JY; Yu, JI; Park, HC; Choi, DH; Yoo, GS; Lee, WY; Yun, SH; Cho, YB; Park, YA; Kim, HC; Nam, H
View PubMed
-
TUMORI 2020 10.1177/0300891620937795
Impact of sarcopenia on survival of pancreatic cancer patients treated with concurrent chemoradiotherapy
Cho1, WK; Yu, JI; Park, HC; Lim, DH; Kim, TH; Chie, EK
View PubMed
-
CANCERS 2020 10.3390/cancers12051300
Clinical Significance of Systemic Inflammation Markers in Newly Diagnosed, Previously Untreated Hepatocellular Carcinoma
Yu1, JI; Park, HC; Yoo, GS; Paik, SW; Choi, MS; Kim, HS; Sohn, I; Nam, H
View PubMed
-
CANCER RES TREAT 2020 10.4143/crt.2019.261
Carcinoembryonic Antigen Improves the Performance of Magnetic Resonance Imaging in the Prediction of Pathologic Response after Neoadjuvant Chemoradiation for Patients with Rectal Cancer
Yoo1, GS; Park, HC; Yu, JI; Choi, DH; Cho, WK; Park, YS; Park, JO; Lim, HY; Kang, WK; Lee, WY; Kim, HC; Yun, SH; Cho, YB; Park, YA; Song, KD; Kim, SH; Ha, SY
View PubMed
-
CANCERS 2020 10.3390/cancers12040943
Outcomes of Radiotherapy for Mesenchymal and Non-Mesenchymal Subtypes of Gastric Cancer
Yu1, JI; Park, HC; Lee, J; Choi, C; Kang, WK; Park, SH; Kim, ST; Sohn, TS; Lee, JH; An, JY; Choi, MG; Bae, JM; Kim, KM; Han, H; Kim, K; Kim, S; Lim, DH
View PubMed
-
Cancer Med 2019 10.1002/cam4.2570
Clinical significance of radiotherapy before and/or during nivolumab treatment in hepatocellular carcinoma
Yu1, JI; Lee, SJ; Lee, J; Lim, HY; Paik, SW; Yoo, GS; Choi, C; Park, HC
View PubMed
-
J CLIN ONCOL 2019 10.1200/JCO.19.00016
Oxaliplatin-Based Adjuvant Chemotherapy for Rectal Cancer After Preoperative Chemoradiotherapy (ADORE): Long-Term Results of a Randomized Controlled Trial
Hong1, YS; Kim, SY; Lee, JS; Nam, BH; Kim, KP; Kim, JE; Park, YS; Park, JO; Baek, JY; Kim, TY; Lee, KW; Ahn, JB; Lim, SB; Yu, CS; Kim, JC; Yun, SH; Kim, JH; Park, JH; Park, HC; Jung, KH; Kim, TW
View PubMed
-
CANCER RES TREAT 2019 10.4143/crt.2018.687
Treatment Outcome after Fractionated Conformal Radiotherapy for Hepatocellular Carcinoma in Patients with Child-Pugh Classification B Korea (KROG 16-05)
Bae1, SH; Park, HC; Yoon, WS; Yoon, SM; Jung, IN; Lee, IJ; Kim, JW; Seong, J; Kim, TH; Nam, TK; Choi, Y; Lee, SY; Jang, HS; Lee, DS; Kim, JH
View PubMed
-
J APPL CLIN MED PHYS 2019 10.1002/acm2.12718
Feasibility of a GATE Monte Carlo platform in a clinical pretreatment QA system for VMAT treatment plans using TrueBeam with an HD120 multileaf collimator
Lee1, B; Jeong, S; Chung, K; Yoon, M; Park, HC; Han, Y; Jung, SH
View PubMed
-
TUMORI 2019 10.1177/0300891618792476
Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in rectal cancer patients following neoadjuvant chemoradiotherapy
Kim1, TG; Park, W; Kim, H; Choi, DH; Park, HC; Kim, SH; Cho, YB; Yun, SH; Kim, HC; Lee, WY; Lee, J; Kang, KM
View PubMed
-
SCI REP-UK 2019 10.1038/s41598-019-50594-2
Prognostic significance of miR-122 expression after curative resection in patients with hepatocellular carcinoma
Ha1, SY; Yu, JI; Choi, C; Kang, S; Joh, JW; Paik, SW; Kim, S; Kim, M; Park, HC; Park, CK
View PubMed
-
INT J MOL SCI 2019 10.3390/ijms20174297
NOD2 Supports Crypt Survival and Epithelial Regeneration after Radiation-Induced Injury
Lee1, C; Choi, C; Kang, HS; Shin, SW; Kim, SY; Park, HC; Hong, SN
View PubMed
-
ACTA RADIOL 2019 10.1177/0284185118805253
Evaluation of early treatment response to radiotherapy for HCC using pre- and post-treatment MRI
Song1, SH; Jeong, WK; Choi, D; Kim, YK; Park, HC; Yu, JI
View PubMed
-
PLoS One 2019 10.1371/journal.pone.0218049
Targeting DNA-dependent protein kinase sensitizes hepatocellular carcinoma cells to proton beam irradiation through apoptosis induction
Choi1, C; Son, A; Lee, GH; Shin, SW; Park, S; Ahn, SH; Chung, Y; Yu, JI; Park, HC
View PubMed
-
WORLD J GASTROENTERO 2019 10.3748/wjg.v25.i20.2416
Optimizing radiotherapy with immune checkpoint blockade in hepatocellular carcinoma
Choi1, C; Yoo, GS; Cho, WK; Park, HC
View PubMed
-
ANN SURG 2019 10.1097/SLA.0000000000002582
Anastomotic Leak Does Not Impact Oncologic Outcomes After Preoperative Chemoradiotherapy and Resection for Rectal Cancer
Jang1, JH; Kim, HC; Huh, JW; Park, YA; Cho, YB; Yun, SH; Lee, WY; Yu, JI; Park, HC; Park, YS; Park, JO
View PubMed
-
INT J MOL SCI 2019 10.3390/ijms20081894
Comparison of Proton and Photon Beam Irradiation in Radiation-Induced Intestinal Injury Using a Mouse Model
Choi1, C; Lee, C; Shin, SW; Kim, SY; Hong, SN; Park, HC
View PubMed
-
J RADIAT RES 2019 10.1093/jrr/rry102
Concurrent chemo-radiotherapy for unresectable non-small cell lung cancer invading adjacent great vessels on radiologic findings: is it safe?
Yoo1, GS; Oh, D; Pyo, H; Ahn, YC; Noh, JM; Park, HC; Lim, DH
View PubMed
-
SURGERY 2019 10.1016/j.surg.2018.08.026
Tumor regression grade as a clinically useful outcome predictor in patients with rectal cancer after preoperative chemoradiotherapy
Huh1, JW; Kim, HC; Kim, SH; Park, YA; Cho, YB; Yun, SH; Lee, WY; Park, HC; Choi, DH; Park, JO; Park, YS; Chun, HK
View PubMed
-
PLoS One 2019 10.1371/journal.pone.0210730
Multidisciplinary approach is associated with improved survival of hepatocellular carcinoma patients
Sinn1, DH; Choi, GS; Park, HC; Kim, JM; Kim, H; Song, KD; Kang, TW; Lee, MW; Rhim, H; Hyun, D; Cho, SK; Shin, SW; Jeong, WK; Kim, SH; Il Yu, J; Ha, SY; Lee, SJ; Lim, HY; Kim, K; Ahn, JH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Joh, JW; Lim, HK; Paik, SW
View PubMed
-
MAR DRUGS 2018 10.3390/md16120510
Fucoidan-Manganese Dioxide Nanoparticles Potentiate Radiation Therapy by Co-Targeting Tumor Hypoxia and Angiogenesis
Shin1, SW; Jung, W; Choi, C; Kim, SY; Son, A; Kim, H; Lee, N; Park, HC
View PubMed
-
Ann Transl Med 2018 10.21037/atm.2018.08.28
Local modalities for inoperable hepatocellular carcinoma: radiofrequency ablation versus stereotactic body radiotherapy
Bae1, SH; Park, HC
View PubMed
-
J GASTROINTEST SURG 2018 10.1007/s11605-018-3815-9
Prognostic Role of Carcinoembryonic Antigen Level after Preoperative Chemoradiotherapy in Patients with Rectal Cancer
Huh1, JW; Yun, SH; Kim, SH; Park, YA; Cho, YB; Kim, HC; Lee, WY; Park, HC; Choi, DH; Park, JO; Park, YS; Chun, HK
View PubMed
-
ANTICANCER RES 2018 10.21873/anticanres.12808
Treatment of Naive HCC Combined with Segmental or Subsegmental Portal Vein Tumor Thrombosis: Liver Resection Versus TACE Followed by Radiotherapy
Yu1, JI; Choi, GS; Lim, DH; Lee, E; Joh, JW; Kwon, CHD; Kim, JM; Kim, S; Woo, SY; Paik, SW; Park, HC
View PubMed
-
WORLD J GASTROENTERO 2018 10.3748/wjg.v24.i28.3090
Proton therapy for hepatocellular carcinoma: Current knowledges and future perspectives
Yoo1, GS; Yu, JI; Park, HC
View PubMed
-
CANCER RES TREAT 2018 10.4143/crt.2017.252
The Impact of Surgical Timing on Pathologic Tumor Response after Short Course and Long Course Preoperative Chemoradiation for Locally Advanced Rectal Adenocarcinoma
Lee1, SW; Lee, JH; Lee, IK; Oh, ST; Kim, DY; Kim, TH; Oh, JH; Baek, JY; Chang, HJ; Park, HC; Kim, HC; Chie, EK; Nam, TK; Jang, HS
View PubMed
-
PHYS MED BIOL 2018 10.1088/1361.6560/aac27b
Feasibility study of Fe3O4/TaOx nanoparticles as a radiosensitizer for proton therapy
Ahn1, SH; Lee, N; Choi, C; Shin, SW; Han, Y; Park, HC
View PubMed
-
SCI REP-UK 2018 10.1038/s41598-018-24745-w
Radiosensitization by Marine Sponge Agelas sp Extracts in Hepatocellular Carcinoma Cells with Autophagy Induction
Choi1, C; Son, A; Lee, HS; Lee, YJ; Park, HC
View PubMed
-
CANCER RES TREAT 2018 10.4143/crt.2016.607
Redefining the Positive Circumferential Resection Margin by Incorporating Preoperative Chemoradiotherapy Treatment Response in Locally Advanced Rectal Cancer: A Multicenter Validation Study
Lee1, JH; Chie, EK; Jeong, SY; Kim, TY; Kim, DY; Kim, TH; Kim, SY; Baek, JY; Chang, HJ; Kim, MJ; Park, SC; Oh, JH; Kim, SH; Lee, JH; Choi, DH; Park, HC; Kang, SB; Kim, JS
View PubMed
-
ANTICANCER RES 2018 10.21873/anticanres.12498
Effectiveness and Safety of Tissue Expander for Adjuvant Helical Tomotherapy in Curatively Resected Retroperitoneal Sarcoma
Yu1, JI; Lim, DH; Park, HC; Jung, SH; Jeon, SJ; Nam, H; Kim, B; Kim, SJ; Park, JB
View PubMed
-
ONCOTARGET 2017 10.18632/oncotarget.22511
Elevated CEA is associated with worse survival in recurrent rectal cancer
Cho1, WK; Choi, DH; Park, HC; Park, W; Yu, JI; Park, YS; Park, JO; Lim, HY; Kang, WK; Kim, HC; Cho, YB; Yun, SH; Lee, WY
View PubMed
-
ANTIOXID REDOX SIGN 2017 10.1089/ars.2016.6889
Mechanism of the Antitumor and Radiosensitizing Effects of a Manganese Porphyrin, MnHex-2-PyP
Shin1, SW; Choi, C; Lee, GH; Son, A; Kim, SH; Park, HC; Batinic-Haberle, I; Park, W
View PubMed
-
ONCOTARGET 2017 10.18632/oncotarget.21775
Prognostic group stratification and nomogram for predicting overall survival in patients who received radiotherapy for abdominal lymph node metastasis from hepatocellular carcinoma: a multi-institutional retrospective study (KROG 15-02)
Kim1, Y; Park, HC; Yoon, SM; Kim, TH; Lee, J; Choi, J; Yu, JI; Park, JH; Kim, JH; Park, JW; Seong, J
View PubMed
-
SCI REP-UK 2017 10.1038/s41598-017-15165-3
Valproic Acid Sensitizes Hepatocellular Carcinoma Cells to Proton Therapy by Suppressing NRF2 Activation
Il Yu1, J; Choi, C; Shin, SW; Son, A; Lee, GH; Kim, SY; Park, HC
View PubMed
-
PHYS MED BIOL 2017 10.1088/1361-6560/aa87fd
Study on dependence of dose enhancement on cluster morphology of gold nanoparticles in radiation therapy using a body-centred cubic model
Ahn1, SH; Chung, K; Shin, JW; Cheon, W; Han, Y; Park, HC; Choi, DH
View PubMed
-
J RADIAT RES 2017 10.1093/jrr/rrw131
Development of a real-time internal and external marker tracking system for particle therapy: a phantom study using patient tumor trajectory data
Cho1, J; Cheon, W; Ahn, S; Jung, H; Sheen, H; Park, HC; Han, Y
View PubMed
-
ONCOTARGET 2017 10.18632/oncotarget.20529
Stereotactic ablative body radiotherapy for spinal metastasis from hepatocellular carcinoma: its oncologic outcomes and risk of vertebral compression fracture
Yoo1, GS; Park, HC; Il Yu, J; Lim, DH; Cho, WK; Lee, E; Jung, SH; Han, Y; Kim, ES; Lee, SH; Eoh, W; Park, SJ; Chung, SS; Lee, CS; Lee, JH
View PubMed
-
SCI REP-UK 2017 10.1038/s41598-017-12469-2
Clinical importance of TERT overexpression in hepatocellular carcinoma treated with curative surgical resection in HBV endemic area
Yu1, JI; Choi, C; Ha, SY; Park, CK; Kang, SY; Joh, JW; Paik, SW; Kim, S; Kim, M; Jung, SH; Park, HC
View PubMed
-
ONCOTARGET 2017 10.18632/oncotarget.19219
Intensity-modulated radiotherapy for hepatocellular carcinoma: dosimetric and clinical results
Bae1, SH; Jang, WI; Park, HC
View PubMed
-
ONCOTARGET 2017 10.18632/oncotarget.17072
Combination treatment with transarterial chemoembolization, radiotherapy, and hyperthermia (CERT) for hepatocellular carcinoma with portal vein tumor thrombosis: Final results of a prospective phase II trial
Yu1, JI; Park, HC; Jung, SH; Choi, C; Shin, SW; Cho, SK; Sinn, DH; Paik, YH; Gwak, GY; Choi, MS; Lee, JH; Koh, KC; Yoo, BC; Sahinbas, H; Paik, SW
View PubMed
-
TUMORI 2017 10.5301/tj.5000666
Clinical outcomes of salvage chemoradiotherapy for locally recurrent biliary tract cancer
Yu1, JI; Park, HC; Lim, DH; Park, JO; Park, YS; Kim, ST; Choi, SH; Choi, DW; Han, IW; Heo, JS
View PubMed
-
Liver Transpl. 2017 Apr;23(4):545-551. doi: 10.1002/lt.24729.
The possibility of radiotherapy as downstaging to living donor liver transplantation for hepatocellular carcinoma with portal vein tumor thrombus
Choi JY11, Yu JI2, Park HC2, David Kwon CH3, Kim JM3, Joh JW3, Choi GS3, Park JB3, Kim SJ3, Lee SH4, Cho WT5, Lee KW3, Na BG3, Oh DK3, Lee N3, Cho CW3, Lee S3, Lee SK3.
View PubMed
-
Jpn J Clin Oncol. 2017 Apr 1;47(4):328-333. doi: 10.1093/jjco/hyw205.
Predictive factors of gastroduodenal bleeding after postoperative radiotherapy in biliary tract cancer
Lee J11, Lim DH1, Park HC1, Yu JI1, Choi DW2, Choi SH2, Heo JS2.
View PubMed
-
Surg Oncol. 2017 Mar;26(1):96-104. doi: 10.1016/j.suronc.2017.01.005. Epub 2017 Feb 2.
Long-term prognostic value of preoperative anemia in patients with colorectal cancer: A systematic review and meta-analysis
Wilson MJ11, van Haaren M2, Harlaar JJ3, Park HC4, Bonjer HJ5, Jeekel J6, Zwaginga JJ7, Schipperus M8.
View PubMed
-
Liver Int. 2017 Feb;37(2):308-309. doi: 10.1111/liv.13278.
Response to Is radiotherapy the best option for treating hepatocellular carcinoma with PVTT?
Im JH11, Yoon SM2, Park HC3,4, Kim JH2, Yu JI3,4, Kim TH5, Kim JW6, Nam TK7, Kim K8, Jang HS9, Kim JH10, Kim MS11, Yoon WS12, Jung I13, Seong J1.
View PubMed
-
Sci Rep. 2017 Jan 19;7:40922. doi: 10.1038/srep40922.
Development of patient-specific phantoms for verification of stereotactic body radiation therapy planning in patients with metallic screw fixation
Oh D11, Hong CS1, Ju SG1, Kim M1, Koo BY1, Choi S1, Park HC1, Choi DH1, Pyo H1.
View PubMed
-
Liver Int. 2017 Jan;37(1):90-100. doi: 10.1111/liv.13191. Epub 2016 Jul 12.
Radiotherapeutic strategies for hepatocellular carcinoma with portal vein tumour thrombosis in a hepatitis B endemic area
Im JH11, Yoon SM2, Park HC3,4, Kim JH2, Yu JI3,4, Kim TH5, Kim JW6, Nam TK7, Kim K8, Jang HS9, Kim JH10, Kim MS11, Yoon WS12, Jung I13, Seong J1.
View PubMed
-
Cancer Res Treat. 2017 Jan;49(1):61-69. doi: 10.4143/crt.2016.097. Epub 2016 Jun 13.
Clinical Practice Patterns of Radiotherapy in Patients with Hepatocellular Carcinoma: A Korean Radiation Oncology Group Study (KROG 14-07)
Cha H11,2, Park HC2,3, Yu JI2, Kim TH4, Nam TK5, Yoon SM6, Yoon WS7, Kim JW8, Kim MS9, Jang HS10, Choi Y11, Kim JH12, Kay CS13, Jung I14, Seong J1.
View PubMed
-
J Radiat Res. 2017 Jan;58(1):155-163. doi: 10.1093/jrr/rrw089. Epub 2016 Sep 26.
Spine Metastasis Practice Patterns among Korean, Chinese, and Japanese Radiation Oncologists: A Multinational Online Survey Study
Yu JI11, Park HC2,3, Ahn YC1,3, Gao XS4, Wang JJ5, Zeng ZC6, Ito Y7, Ohno T8, Nishimura Y9.
View PubMed
-
Support Care Cancer. 2016 Oct;24(10):4399-406. doi: 10.1007/s00520-016-3280-5. Epub 2016 May 24.
Evaluation of quality of life using a tablet PC-based survey in cancer patients treated with radiotherapy: a multi-institutional prospective randomized crossover comparison of paper and tablet PC-based questionnaires (KROG 12-01)
Kim H11, Park HC2,3, Yoon SM4, Kim TH5, Kim J6, Kang MK7, Jung J8, Kim SW7, Yea JW7, Park SH9, Park YS10.
View PubMed
-
STRAHLENTHERAPIE UND ONKOLOGIE, OCT 2016, 192(10):714-721, DOI: 10.1007/s00066-016-1028-2
Interobserver variability in gross tumor volume delineation for hepatocellular carcinoma
Kim YS1, Kim JW, Yoon WS, Kang MK, Lee IJ, Kim TH, Kim JH, Lee HS, Park HC, Jang HS
View PubMed
-
Oncotarget. 2016 Sep 20;7(38):62676-62686. doi: 10.18632/oncotarget.10445.
Prognostic significance of survivin in rectal cancer patients treated with surgery and postoperative concurrent chemo-radiation therapy
Yu JI11, Lee H2, Park HC1, Choi DH1, Choi YL3, Do IG4, Kim HC5, Lee WY5, Yun SH5, Cho YB5, Huh JW5, Park YA6, Park YS6, Park JO6, Kim ST6, Park W1.
View PubMed
-
World J Gastroenterol. 2016 Aug 14;22(30):6851-63. doi: 10.3748/wjg.v22.i30.6851.
Radiotherapy as valid modality for hepatocellular carcinoma with portal vein tumor thrombosis
Yu JI11, Park HC1.
View PubMed
-
Cancer Res Treat. 2016 Jul;48(3):1102-9. doi: 10.4143/crt.2015.207. Epub 2015 Dec 2.
Variation in Practice Patterns of Korean Radiation Oncologists for Spine Metastasis between 2009 and 2014
Yu JI11, Park HC1,2, Ahn YC1,2, Chung Y1, Koom WS3, Song SY4.
View PubMed
-
Medicine (Baltimore). 2016 Jul;95(28):e4123. doi: 10.1097/MD.0000000000004123.
Clinical outcomes of tissue expanders on adjuvant radiotherapy of resected retroperitoneal sarcoma
Yu JI11, Lim do H, Park HC, Nam H, Kim BK, Kim SJ, Park JB.
View PubMed
-
J Cancer Res Clin Oncol. 2016 Jun;142(6):1377-85. doi: 10.1007/s00432-016-2148-x. Epub 2016 Mar 24.
Metformin enhances the response to radiotherapy in diabetic patients with rectal cancer
Oh BY11, Park YA1, Huh JW1, Cho YB1, Yun SH1, Lee WY1, Park HC2, Choi DH2, Park YS3, Kim HC4.
View PubMed
-
Int J Hyperthermia. 2016 May;32(3):331-8. doi: 10.3109/02656736.2016.1144895. Epub 2016 Feb 25.
Combination treatment of trans-arterial chemo-embolisation, radiotherapy and hyperthermia (CERT) for hepatocellular carcinoma with portal vein tumour thrombosis: Interim analysis of prospective phase II trial
Yu JI11, Park HC1,2, Oh D1, Noh JM1, Jung SH1, Kim HY1, Shin SW3, Cho SK3, Sinn DH4, Paik YH4, Gwak GY4, Choi MS4, Lee JH4, Koh KC4, Paik SW4, Yoo BC5.
View PubMed
-
Cancer Res Treat. 2016 Apr;48(2):574-82. doi: 10.4143/crt.2015.076. Epub 2015 Jul 17.
Do Biliary Complications after Hypofractionated Radiation Therapy in Hepatocellular Carcinoma Matter?
Yu JI11, Park HC1, Lim DH1, Paik SW2.
View PubMed
-
Gut Liver. 2016 Mar;10(2):164-5. doi: 10.5009/gnl16014.
Is the Use of Intensity-Modulated Radiotherapy Beneficial for Pancreatic Cancer Patients
1,Park HC1.
View PubMed
-
PLoS One. 2016 Mar 29;11(3):e0152642. doi: 10.1371/journal.pone.0152642. eCollection 2016.
Radiotherapy for Adrenal Metastasis from Hepatocellular Carcinoma: AMulti-Institutional Retrospective Study (KROG 13-05)
Jung J11, Yoon SM2, Park HC3,4, Nam TK5, Seong J6, Chie EK7, Kim TH8, Kim MS9, Kim CY10, Jang HS11, Kim JH2.
View PubMed
-
Radiother Oncol. 2016 Feb;118(2):408-15. doi: 10.1016/j.radonc.2015.11.019. Epub 2016 Jan 28.
Clinical impact of combined transarterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: An external validation study
Yu JI11, Park JW2, Park HC3, Yoon SM4, Lim do H1, Lee JH5, Lee HC6, Kim SW7, Kim JH2.
View PubMed
-
Tumori. 2016 Jan-Feb;102(1):114-21. doi: 10.5301/tj.5000439. Epub 2015 Oct 7.
Clinical significance of mucinous rectal adenocarcinoma following preoperative chemoradiotherapy and curative surgery
Kim TG11, Park W2, Choi DH2, Park HC2, Kim SH3, Cho YB4, Yun SH4, Kim HC4, Lee WY4, Lee J5, Park JO5, Park YS5, Lim HY5, Kang WK5, Chun HK6.
View PubMed
-
Medicine (Baltimore). 2016 Jan;95(3):e2582. doi: 10.1097/MD.0000000000002582.
Mismatch Repair Gene Expression as a Predictor of Tumor Responses in Patients With Rectal Cancer Treated With Preoperative Chemoradiation
Huh JW11, Kim HC, Kim SH, Park YA, Cho YB, Yun SH, Lee WY, Park HC, Choi DH, Park JO, Park YS, Chun HK.
View PubMed
-
Cancer Res Treat. 2015 Oct;47(4):727-37. doi: 10.4143/crt.2014.018. Epub 2014 Dec 2.
Dosimetric and Clinical Influence of 3D Versus 2D Planning in Postoperative Radiation Therapy for Gastric Cancer
Lee JA11, Ahn YC2, Lim do H2, Park HC2, Asranbaeva MS3.
View PubMed
-
Med Phys. 2015 Oct;42(10):6021-7. doi: 10.1118/1.4931411.
A virtual simulator designed for collision prevention in proton therapy
Jung H11, Kum O2, Han Y3, Park HC3, Kim JS3, Choi DH3.
View PubMed
-
World J Surg Oncol. 2015 Jul 29;13:227. doi: 10.1186/s12957-015-0637-z.
Predictors and patterns of recurrence after curative liver resection in intrahepatic cholangiocarcinoma, for application of postoperative radiotherapy: a retrospective study
Gil E11, Joh JW2, Park HC3, Yu JI4, Jung SH4, Kim JM5.
View PubMed
-
Oncology. 2015;89(1):14-22. doi: 10.1159/000371390. Epub 2015 Mar 11.
Is Chemoradiotherapy Beneficial for Stage IV Rectal Cancer
Huh JW11, Kim HC, Park HC, Choi DH, Park JO, Park YS, Park YA, Cho YB, Yun SH, Lee WY, Chun HK.
View PubMed
-
Korean J Radiol. 2015 May-Jun;16(3):465-522. doi: 10.3348/kjr.2015.16.3.465. Epub 2015 May 13.
2014 Korean Liver Cancer Study Group-National Cancer Center Korea Practice Guideline for the Management of Hepatocellular Carcinoma
Korean Liver Cancer Study Group (KLCSG); National Cancer Center1, Korea (NCC).
View PubMed
-
Med Phys. 2015 May;42(5):2626-37. doi: 10.1118/1.4916663.
Preclinical investigation for developing injectable fiducial markers using a mixture of BaSO4 and biodegradable polymer for proton therapy
Ahn SH11, Gil MS2, Lee DS2, Han Y3, Park HC3, Sohn JW4, Kim HY5, Shin EH5, Yu JI3, Noh JM3, Cho JS3, Ahn SH3, Choi DH3.
View PubMed
-
Cancer Res Treat. 2015 Apr;47(2):251-8. doi: 10.4143/crt.2014.011. Epub 2014 Oct 27.
Changes in Arterioportal Shunts in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis Who Were Treated with Chemoembolization Followed by Radiotherapy
Oh D11, Shin SW2, Park HC1, Cho SK2, Lim do H1, Paik SW3.
View PubMed
-
Ann Surg Oncol. 2015 Apr;22(4):1308-14. doi: 10.1245/s10434-014-4146-z. Epub 2014 Oct 16.
Salvage Radiation Therapy for Isolated Local Recurrence of Extrahepatic Cholangiocarcinoma After Radical Surgery: A Retrospective Study
Kim SW11, Lim do H, Park HC, Park W, Park JO, Park YS.
View PubMed
-
J Surg Oncol.?2015 Mar 15;111(4):439-44. doi: 10.1002/jso.23835. Epub 2014 Dec 9.
Adjuvant Chemotherapy After Neoadjuvant Chemoradiation and Curative Resection for Rectal Cancer: Is it Necessary for all Patients
Jung KU11,?Kim HC,?Park JO,?Park YS,?Park HC,?Choi DH,?Cho YB,?Yun SH,?Lee WY,?Chun HK.
View PubMed
-
Yonsei Med J. 2015 Jan;56(1):82-8. doi: 10.3349/ymj.2015.56.1.82.
Immunohistochemical Detection of p53 Expression in Patients with Preoperative Chemoradiation for Rectal Cancer: Association with Prognosis
Huh JW11, Lee WY2, Kim SH3, Park YA1, Cho YB1, Yun SH1, Kim HC1, Park HC4, Choi DH4, Park JO5, Park YS5, Chun HK6.
View PubMed
-
Tumori. 2014 Nov-Dec;100(6):645-51. doi: 10.1700/1778.19270.
Child-Pugh score maintenance in cirrhotic hepatocellular carcinoma patients after radiotherapy: aspects of gastroduodenal complications
Yu JI1, Cho JY, Park HC, Lim do H, Gwak GY, Paik SW.
View PubMed
-
Dig Dis. 2014;32(6):755-63. doi: 10.1159/000368018. Epub 2014 Oct 29.
Considerations for Radiation Therapy in Hepatocellular Carcinoma: The Radiation Oncologists' Perspective
Yu JI11, Park HC.
View PubMed
-
Cancer Res Treat. 2014 Oct;46(4):348-57. doi: 10.4143/crt.2013.142. Epub 2014 Jul 16.
Multicenter Validation Study of a Prognostic Index for Portal Vein Tumor Thrombosis in Hepatocellular Carcinoma
Yu JI11, Yoon SM2, Park HC1, Kim JH2, Kim TH3, Park JW3, Seong J4, Lee IJ4, Jang HS5, Kay CS6, Kim CY7, Chie EK8, Kim JH9, Kim MS10, Choi YM11.
View PubMed
-
Radiother Oncol. 2014 Oct;113(1):18-23. doi: 10.1016/j.radonc.2014.08.016. Epub 2014 Sep 19.
Prediction of pathologic staging with magnetic resonance imaging after preoperative chemoradiotherapy in rectal cancer: Pooled analysis of KROG 10-01 and 11-02
Lee JH11, Jang HS2, Kim JG3, Lee MA4, Kim DY5, Kim TH5, Oh JH5, Park SC5, Kim SY5, Baek JY5, Park HC6, Kim HC7, Nam TK8, Chie EK9, Jung JH10, Oh ST11.
View PubMed
-
Lancet Oncol. 2014 Oct;15(11):1245-53. doi: 10.1016/S1470-2045(14)70377-8. Epub 2014 Sep 4.
Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial
Hong YS11, Nam BH2, Kim KP1, Kim JE1, Park SJ1, Park YS3, Park JO3, Kim SY4, Kim TY5, Kim JH6, Ahn JB7, Lim SB8, Yu CS8, Kim JC8, Yun SH9, Kim JH10, Park JH10, Park HC11, Jung KH1, Kim TW12.
View PubMed
-
Cancer Res Treat. 2014 Jul;46(3):243-9. doi: 10.4143/crt.2014.46.3.243. Epub 2014 Jul 15.
Outcome of Local Excision Following Preoperative Chemoradiotherapy for Clinically 12 Distal Rectal Cancer: A Multicenter Retrospective Study (KROG 12-06)
Noh JM11, Park W, Kim JS, Koom WS, Kim JH, Choi DH, Park HC.
View PubMed
-
Int J Radiat Oncol Biol Phys. 2014 Jul 15;89(4):814-21. doi: 10.1016/j.ijrobp.2014.03.020.
The Role of Diffusion-Weighted Magnetic Resonance Imaging in the Treatment Response Evaluation of Hepatocellular Carcinoma Patients Treated With Radiation Therapy
Yu JI11, Park HC2, Lim do H1, Choi Y1, Jung SH1, Paik SW3, Kim SH4, Jeong WK4, Kim YK4.
View PubMed
-
Liver Int. 2014 May;34(5):795-801. doi: 10.1111/liv.12445. Epub 2014 Jan 12.
The feasibility of combined transcatheter arterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma
Cho JY11, Paik YH, Park HC, Yu JI, Sohn W, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.
View PubMed
-
Med Phys.?2014 Feb;41(2):021712. doi: 10.1118/1.4860155.
Dosimetric effects of multileaf collimator leaf width on intensity-modulated radiotherapy for head and neck cancer
Hong CS11,?Ju SG1,?Kim M1,?Kim JI2,?Kim JM1,?Suh TS3,?Han Y1,?Ahn YC1,?Choi DH1,?Nam H2,?Park HC1.
View PubMed
-
Int J Colorectal Dis. 2014 Feb;29(2):193-200. doi: 10.1007/s00384-013-1797-3. Epub 2013 Dec 10.
Factors associated with lateral pelvic recurrence after curative resection following neoadjuvant chemoradiotherapy in rectal cancer patients
Kim TG11, Park W, Choi DH, Park HC, Kim SH, Cho YB, Yun SH, Kim HC, Lee WY, Lee J, Park JO, Park YS, Lim HY, Kang WK, Chun HK.
View PubMed
-
Radiother Oncol. 2014 Jan;110(1):150-4. doi: 10.1016/j.radonc.2013.11.013. Epub 2014 Jan 7.
Two-week course of preoperative chemoradiotherapy followed by delayed surgery for rectal cancer: A phase II multi-institutional clinical trial (KROG 11-02)
Lee JH11, Kim JG2, Oh ST2, Lee MA3, Chun HG3, Kim DY4, Kim TH4, Kim SY4, Baek JY4, Park JW4, Oh JH4, Park HC5, Choi DH5, Park YS6, Kim HC7, Chie EK8, Jang HS9.
View PubMed
-
AJR Am J Roentgenol. 2014 Jan;202(1):92-101. doi: 10.2214/AJR.12.10212.
Added Value of Diffusion-Weighted MRI for Evaluating Viable Tumor of Hepatocellular Carcinomas Treated With Radiotherapy in Patients With Chronic Liver Disease
Park HJ11, Kim SH, Jang KM, Lim S, Kang TW, Park HC, Choi D.
View PubMed
-
Med Dosim. 2013 Winter;38(4):359-65. doi: 10.1016/j.meddos.2013.04.002. Epub 2013 Jun 12.
Cumulative dose on fractional delivery of tomotherapy to periodically moving organ: A phantom QA suggestion
Shin E11, Han Y, Park HC, Sung Kim J, Hwan Ahn S, Suk Shin J, Gyu Ju S, Ho Choi D, Lee J.
View PubMed
-
Recent advances in the management of hepatocellular carcinoma
-
Recent developments in radiotherapy for hepatocellular carcinoma
-
Strahlenther Onkol. 2013 Jul;189(7):541-6. doi: 10.1007/s00066-013-0343-0. Epub 2013 May 25.
Predictive factors for gastroduodenal toxicity based on endoscopy following radiotherapy in patients with hepatocellular carcinoma
Yoon H11, Oh D, Park HC, Kang SW, Han Y, Lim DH, Paik SW.
View PubMed
-
Am J Clin Oncol. 2013 Apr;36(2):162-6. doi: 10.1097/COC.0b013e3182438dae.
The Efficacy of High-dose 3-Dimensional Conformal Radiation Therapy in Patients With Small Hepatocellular Carcinoma Not Eligible for Other Local Modalities
Lim do H11, Lee H, Park HC, Lee JA, Kim SW, Yoo BC, Koh KC, Lee JH, Choi MS, Gwak GY, Paik SW.
View PubMed
-
Tumori. 2013 Mar-Apr;99(2):164-71. doi: 10.1700/1283.14187.
Predictive factors for Child-Pugh score elevation in hepatocellular carcinoma patients treated with conformal radiation therapy: dose-volume histogram analysis
Yu JI11, Park HC, Lim do H, Park WY.
View PubMed
-
Br J Radiol. 2013 Jan;86(1021):20120221. doi: 10.1259/bjr.20120221.
Evaluation of anatomical landmark position differences between respiration-gated MRI and four-dimensional CT for radiation therapy in patients with hepatocellular carcinoma
Yu JI11, Kim JS, Park HC, Lim DH, Han YY, Lim HC, Paik SW.
View PubMed
-
Cancer. 2012 Oct 15;118(20):4961-8. doi: 10.1002/cncr.27507. Epub 2012 Mar 13.
Can the New American Joint Committee on Cancer Staging System Predict Survival in Rectal Cancer Patients Treated With Curative Surgery Following Preoperative Chemoradiotherapy
Moon SH11, Kim DY, Park JW, Oh JH, Chang HJ, Kim SY, Kim TH, Park HC, Choi DH, Chun HK, Kim JH, Park JH, Yu CS.
View PubMed
-
J Korean Med Sci. 2012 Jul;27(7):736-43. doi: 10.3346/jkms.2012.27.7.736. Epub 2012 Jun 29.
Scheduled Interval Trans-Catheter Arterial Chemoembolization Followed by Radiation Therapy in Patients with Unresectable Hepatocellular Carcinoma
Yu JI11, Park HC, Lim do H, Kim CJ, Oh D, Yoo BC, Paik SW, Kho KC, Lee JH.
View PubMed
-
Med Phys. 2012 May;39(5):2396-404. doi: 10.1118/1.3700734.
Development of a video-guided real-time patient motion monitoring system
Ju SG11, Huh W, Hong CS, Kim JS, Shin JS, Shin E, Han Y, Ahn YC, Park HC, Choi DH.
View PubMed
-
Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):e603-7. doi: 10.1016/j.ijrobp.2011.09.053. Epub 2011 Dec 28.
Salvage Treatment With Hypofractionated Radiotherapy in Patients With Recurrent Small Hepatocellular Carcinoma
Bae SH11, Park HC, Lim do H, Lee JA, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.
View PubMed
-
Technol Cancer Res Treat. 2012 Feb;11(1):41-8.
Volumetric Response Evaluation After Intensity Modulated Radiotherapy in Patients with Supratentorial Gliomas
Cho KH11, Choi JH, Kim JY, Lee SH, Yoo H, Shin KH, Kim TH, Moon SH, Lee SH, Park HC.
View PubMed
-
Oncology. 2011;81 Suppl 1:134-40. doi: 10.1159/000333276. Epub 2011 Dec 22.
Multidisciplinary Management of Nonresectable Hepatocellular Carcinoma
Park HC11, Seong J, Tanaka M, Zeng ZC, Lim HY, Guan S, Bae SH, Tak WY.
View PubMed
-
J Korean Med Sci. 2011 Aug;26(8):1014-22. doi: 10.3346/jkms.2011.26.8.1014. Epub 2011 Jul 27.
Prognostic Index for Portal Vein Tumor Thrombosis in Patients with Hepatocellular Carcinoma Treated with Radiation Therapy
Yu JI11, Park HC, Lim do H, Park W, Yoo BC, Paik SW, Koh KC, Lee JH.
View PubMed
-
Radiation Therapy for Colorectal Cancer
-
Yonsei Med J. 2010 Jan;51(1):93-9. doi: 10.3349/ymj.2010.51.1.93. Epub 2009 Dec 29.
High Dose Three-Dimensional Conformal Boost Using the Real-Time Tumor Tracking Radiotherapy System in Cervical Cancer Patients Unable to Receive Intracavitary Brachytherapy
Park HC11, Shimizu S, Yonesaka A, Tsuchiya K, Ebina Y, Taguchi H, Katoh N, Kinoshita R, Ishikawa M, Sakuragi N, Shirato H.
View PubMed
-
J Korean Med Sci. 2009 Apr;24(2):248-55. doi: 10.3346/jkms.2009.24.2.248. Epub 2009 Apr 20.
Multi-institutional Comparison of Intensity Modulated Radiation Therapy (IMRT) Planning Strategies and Planning Results for Nasopharyngeal Cancer
Park SH11, Park HC, Park SW, Oh do H, Choi Y, Kim JK, Ahn YC, Park W, Suh HS, Lee R, Bae H.
View PubMed
-
Jpn J Clin Oncol. 2009 Mar;39(3):151-7. doi: 10.1093/jjco/hyn158. Epub 2009 Feb 3.
Prediction of Radiation Pneumonitis Following High-dose Thoracic Radiation Therapy by 3 Gy/fraction for Non-small Cell Lung Cancer: Analysis of Clinical and Dosimetric Factors
Oh D11, Ahn YC, Park HC, Lim do H, Han Y.
View PubMed